具体需求见附件

具体需求在上传的附件里

需求内容在上传的附件里

需求的内容在上传的附件里

1、Przemysl Chemiczny, 85(5), 349-350; 2006 2、Polymorphism of sodium valproate 【作 者】Mifsud, H.;Miguel, L.;Lavastre, V.;Maire, G. 【刊 名】Calorim. Anal. Therm. 【出版日期】1993 【卷 号】Vol.24 【页 码】309-312 3、Standards, Options and Recommendations (SOR) for endocrine therapy in patients with non metastatic breast cancer. FNCLCC 4、[Standards, Options and Recommendations (SOR) for tumor markers in breast cancer. SOR Working Group] 5、Ital J Gastroenterol. 1995 Sep;27(7):376-7. TUDCA and UDCA are incorporated into hepatocyte membranes: different sites, but similar effects. Leuschner U1, Guldutuna S, Bhatti S, Elze A, Imhof M, You T, Zimmer G. Author information 6、AJHYA2 American Journal of Hygiene. (Baltimore, MD) V.1-80, 1921-64. For publisher information, see AJEPAS. Volume(issue)/page/year: 76,209,1962

需求内容在图片里面

1、Arzneimittelforschung. 1985;35(7A):1203-8. Ohashi S, Iwatani M, Hyakuna Y, Morioka Y. Thermographic evaluation of the hemodynamic effect of the antithrombotic drug cilostazol in peripheral arterial occlusion. 2、Arzneimittelforschung. 1985;35(7A):1149-54. K Kawamura, K Watanabe, Y Kimura. Effect of cilostazol, a new antithrombotic drug, on cerebral circulation 3、Gel formation of cefpodoxime proxetil 4、Gas chromatographic analysis of fosfomycin in plasma for pharmacokinetic analysis. GK Webster, RG Bell - Journal of AOAC International, 1999 - europepmc.org 5、Rydell N, Butler J, Balazs EA. Hyaluronic acid in synovial fluid.Ⅵ. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of the arthritis in track horses. Acta Vet Scand, 1970,11:139~146 6、Peyron JG, Balazs EA. Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Pathol Biol, 1974, 22:731~736 7、Weiss C, Balazs EA, St Onge R, et al. Clinical studies of the intra-articular injection of Healon in the treatment of osteoarthritis of human knee. Semin Arhtritis Rheum, 1980, 11(Suppl 1):143~144 8、Punzi L, Schiavon F, Ramonda R, et al. Intra-articular hyaluronic acid in the treatment of inflammatory and non-inflammatory knee diffusions. Curr Ther Res, 1988, 43:643~647 9、Nolan JP, reducing Catheter Related Bacteraemia in Haemodialysis. Vascular Access Soc. 5th Int. Congress of Vascular Access Soc, Nice, 2007 10、Arzneimittelforschung. 1984;34(9):948-52. Iron derivatives of modified milk protein.

文献： 1、" Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature. " Pharmacotherapy 2007;27:290–8. Page RL, Schwiesow J, Hilts A. 2、Mucormycosis treated with posaconazole: review of 96 case reports. Crit Rev Microbiol 2013;39:310–24. Vehreschild JJ, Birtel A, Vehreschild MJGT, et al. 3、Tarantino MD, Fogarty P, Mayer B, Vasey SY, Brainsky A. Efficacy of eltrombopag in management of bleeding symptoms associated with chronic immune thrombocytopenia. Blood Coagul Fibrinolysis. 2013 Apr;24(3):284-96. doi: 10.1097/MBC.0b013e32835fac99. 4、J Med Chem, 51: 4632～4640. Org. Process Res. Dev. 2019, 23, 9, 2057-2068 Pharmazie 73(9):494-497 · September 2018 5、中国医药工业杂志 2012， 43（8）， 644-646 6、精细化工中间体2013，43（2），46-48 7、精细化工中间体2011，41（4），46-48 8、中国现代应用药学2011，28（1），58-59 9、Chemical biology&Drug Design 2014, 83(3), 306-316 10、Letters in organic chemistry 2012, 9(4), 276-279 11、Medicines Evidence Commentary : Chronic kidney disease: calcium-based versus non-calcium-based phosphate binders Source: National Institute for Health and Care Excellence - NICE - 21 January 2014 - Publisher: National Institute for Health and Care Excellence (NICE) 12、double-blind comparison of calcium chloride and calcium gluconate therapies for hypocalcemia in critically ill children 13、J. Med. Chem. 2018, 61, 5304−5322. 14、Chem. Biol. Drug Des. 2014, 83, 306−316. 15、J. Pharm. Biomed. Anal. 2009, 50, 144−150. 16、Int. J. Pharm. Sci. 2016, 8, 97−102. 17、J. Pharm. Biomed. Anal. 2010, 52, 493−507. 18、Org. Process Res. Dev. 2013, 17, 1036−1041. 19、Beilstein J. Org. Chem. 2011, 7, 442− 495. 20、Bioorg. Med. Chem. Lett. 2014, 24, 1108−1110. 21、New Activated PEG Derivatives for Affinity Partitioning 22、Population incidence and mortality of sepsis in an urban African setting 2013-2016 23、Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in Adults With Suspected Infection in Low- and Middle-Income Countries 24、In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis J. G. Bueno C. Martinez B. Zapata G. Sanclemente M. Gallego A. C. Mesa First published: 02 July 2010 25、Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004;350:951–2. Marty FM, Cosimi LA, Baden LR. 26、Alterations in L-Histidine Transport in-Rsponse to Aspirin- and Nimesulide- Induced Toxicity in Rat Intestine Using Everted Intestinal Sacs. 27、Drug interactions with nimesulide. 28、Action of Some Steroids on the Central Nervous System of the Mouse. I. Synthetic Methods 29、Scand J Clin Lab Invest. 2001 Apr;61(2):89-94. Bioelectric impedance analysis of acute body water changes in congestive heart failure 30、Oral bioavailability of posaconazole in fasted healthy subjects: comparison between three regimens and basis for clinical dosage recommendations. Clin Pharmacokinet. 2005;44(2):211-20. Ezzet F1, Wexler D, Courtney R, Krishna G, Lim J, Laughlin M. 31、Effect of pH and comedication on gastrointestinal absorption of posaconazole: monitoring of intraluminal and plasma drug concentrations. Clin Pharmacokinet. 2011 Nov 1;50(11):725-34. Walravens J1, Brouwers J, Spriet I, Tack J, Annaert P, Augustijns P. 32、Determination of ornidazole and its main metabolites in biological fluids Author ： overlay panelP.HeizmannR.GeschkeK.Zinapold Journal of Chromatography B: Biomedical Sciences and Applications Volume 534, 1990, Pages 233-240 33、Metabolic Studies of Ornidazole in the Rat, in the Dog and in Man D. E. Schwartz, J.-C. Jordan, W. Vetter & G. Oesterhelt Pages 571-581 | Received 14 Nov 1978, Published online: 30 Sep 2009 Journal Xenobiotica the fate of foreign compounds in biological systems Volume 9, 1979 - Issue 9 34、Systemic Delivery of CRISPR/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors 35、A novel oral capsule can deploy microneedle patches that release drugs into the intestinal wall for uptake into the bloodstream as shown in animal studies, thereby avoiding injections.patch drug delivery in the gut 36、Cyanocobalamin degradation Stanley Scheindlin First published: August 1976 37、Preparation of Polytosylated γ-Cyclodextrins Yamamura, Hatsuo; Kawase, Yoshitaka; Kawai, Masao; Butsugan, Yasuo [Bulletin of the Chemical Society of Japan, 1993, vol. 66, # 2, p. 585 - 588] 38、ＴＥＮＮＥＲＳ，ＢＡＩＬＬＩＥＪ，ＤEＷＩＴＴＪ，ｅｔａｌ．ＡｍｅｒｉｃａｎＣｏｌｌｅｇｅｏｆＧａｓｔｒｏｅｎｔｅｒｏｌｏｇｙｇｕｉｄｅｌｉｎｅ：ｍａｎａｇｅｍｅｎｔｏｆａｃｕｔｅｐａｎｃｒｅａｔｉｔｉｓ［Ｊ］．ＡｍＪＧａｓｔｒｏｅｎｔｅｒｏｌ，２０１３，１０８（９）：１４００－１４１５，１４１ 药典（EP10）： 1、昔萘酸沙美特罗Salmeterol Xinafoate 2、氨基水杨酸钠Sodium Aminosalicylate Dihydrate 3、亚胺培南Imipenem monohydrate 4、西司他丁钠Cilastatin sodium、 5、制霉菌素Nystatin 6、ω-3 脂肪酸甘油三酯Omega-3-Acid Triglycerides 7、噻托溴铵一水合物Tiotropium Bromide Monohydrate 8、硫酸沙丁胺醇Sulbutamol Sulphate 9、Tigecycline EP10.0标准 10、1. 5.4. Residual solvents 11、2. 5.10. Control of impurities in substances for pharmaceutical use 12、Substances for pharmaceutical use (2034) 13、Sitagliptin phosphate monohydrate的EP10.0 14、Losartan potassium 15、valsartan 16、ZolmitriptanEP10.0 17、Cefapirin sodium EP10 18、SODIUM IODIDE (131I) CAPSULES EP10.0 19、磷酸氟达拉滨Fludarabine Phosphate 20、EP10.0的地氯雷他定desloratadine 21、Valproic acid 22、Sodium valproate 23、Minoxidil 24、Quetiapine fumarate 25、Quetiapine fumarate 26、Metoclopramide Hydrochloride

1、Clinical Features and Molecular Genetics of HSD387 Deficiency and AKRlD1 Deficiency A case report of inborn errors of bile acid synthesis 2、3B-hydroxy-△5-C27 steroid dehydrogenase deficiency: a case report 3、Hallas G. Chem. and Ind. 1972,691 4、Chemical and biological characterization of iron-protein succinylate (ITF 282)' 5、Arzneimittelforschung. 1984;34(9):948-52. Iron derivatives of modified milk protein.

EP10.0药典： 1、Piperacillin Sodium EP10.0 2、替加环素Tigecycline EP10.0 3、阿托品atropine EP10.0 4、硫酸阿托品 EP10.0 5、2.6.31 EP10.0 6、EP10.0: Salmeterol Xinafoate 7、EP10.0: Preparations for inhalation 8、EP10.0: Pressurised pharmaceutical preparations" 9、EP10:ceftazidime 10、Formoterol Fumarate EP10.0 11、乳酸依沙吖啶Ethacridine lactate monohydrate EP10.0 12、Aspartame的EP10.0标准 13、EP10.0 3.1.9 14、perindopril tert-butylamine的EP10.1标准 15、CALCIUM LEVOFOLINATE HYDRATE EP10.0 16、Deslanoside EP10 17、Inhalation powders EP10 18、Fluconazole EP10 19、Nifedipine EP10 20、Calcium Dobesilate Monohydrate 羟苯磺酸钙原料药EP10.0的标准 21、EP10.0 Ipratropium bromide 22、Voriconazole EP10.0 23、Magnesium Stearate硬脂酸镁 EP10.0 24、Colloidal Anhydrous Silica胶态无水二氧化硅 EP10.0 25、Purified water 纯化水 EP10.0 26、Povidone (K-90) 聚维酮 (K-90) EP10.0 27、Hydroxypropyl cellulose (EF)羟丙纤维素 (EF) EP10.0 28、HPMC E-15羟丙甲纤维素E-15 EP10.0 29、Purified Talc 滑石粉 EP10.0 30、Pregelatinised Starch 预胶化淀粉 EP10.0 31、Lactose Monohydrate一水乳糖 EP10.0 32、lsopropyl Alcohol异丙醇 EP10.0 33、Titanium dioxide二氧化钛 EP10.0 34、Polyethylene glycol 400 聚乙二醇400 EP10.0 35、氨丁三醇 TROMETAMOL EP10.0 36、依地酸钙钠 SODIUM CALCIUM EDETATE EP10.0 37、碘帕醇 IOPAMIDOL EP10.0 38、甘露醇 MANNITOL 查EP10.0 39、Macrogol 4000 EP10.0 40、盐酸二甲双胍Metformin hydrochloride，EP10.0 41、Polyoxyl castor oil EP10.0 42、Ascorbic Acid-EP10.0 43、EP10.0中的（5.1.8） 44、EP10.0中的（5.1.4） 45、Carboxymethylcellulose sodium的最新欧洲药典，然后这个monograph（专著）里面有一个取代度的具体方法。 EP10.0 46、Tranexamic Acid EP10.0 47、欧洲药典10.0版Starches hydrocyethyl 48、Dextrose和Glucose monohydrate EP10标准 49、Oxcarbazepine EP10标准 50、Human albumin solution EP10标准 51、Cefoperazone Sodium EP10.0 52、Sulbactam Sodium EP10.0 53、Azithromycin、 EP10标准 54、Aripiprazole EP10.0 55、 Candesartan cilexetil EP10.0 56、Clopidogrel besilate EP10.0 57、Clopidogrel hydrogen sulfate EP10.0 58、Clopidogrel hydrochloride EP10.0 59、Duloxetine hydrochloride EP10.0 60、Galantamine hydrobromide EP10.0 61、Irbesartan EP10.0 62、Olmesartan medoxomil EP10.0 63、Pemetrexed disodium heptahydrate EP10.0 64、Pramipexole dihydrochloride monohydrate EP10.0 65、Prasugrel hydrochloride EP10.0 66、Tamsulosin hydrochlorideEP10.0 67、孟鲁司特钠（Montelukast sodium）EP10.0 68、孟鲁司特钠片（Montelukast Sodium Tablets）EP10标准 69、Sodium Benzoate EP10.0 70、Propylene Glycol EP10.0 71、Citric Acid Monohydrate EP10.0 72、Citric Acid Hydrate EP10标准 EP10.0 73、Sodium Citrate EP10标准 74、奥美拉唑钠Omeprazole sodium的质量标准 EP10.0 75、最新版欧洲药典里的枸橼酸质量标准 EP10.0 76、Sodium dihydrogen phosphate dihydrate EP最新版的。 文献： 1、The therapeutic advantage of combination antihypertensive drug therapy using amlodipine and irbesartan in hypertensive patients: Analysis of the post-marketing survey data from PARTNER (Practical combination therapy of Amlodin and angiotensin II Receptor blocker; safety and efficacy in patients with hypertension) study. 2、Preparation of Polytosylated γ-Cyclodextrins Yamamura Hatsuo 1 , Kawase Yoshitaka 1 , Kawai Masao 1 , Butsugan Yasuo 1 3、Fan GP et at, Human Molecular Genetics, 2010, V19:4231. 4、薬剤の臨床 更年期障害ならびに卵巣欠落症状に対するtofisopamの臨床評価，小林拓郎　他：産科と婦人科 49 （2）, 120（1982） 试试这个日文文献 5、二重盲検法によるEGYT-341（Tofisopam）とDiazepamとの薬効比較，臨牀と研究 58(9): 3029-3041, 1981. 6、Tofisopam(MER-19)の自律神経失調症に対する二重盲検比較試験成績，臨牀と研究 62(12): 4045-4060, 1985. 7、頭部・頸部損傷ならびに頸椎疾患に対するTofisopamの臨床的検討―二重盲検法によるγ-oryzanolとの薬効比較―，臨牀と研究 60(6): 2093-2104, 1983. 8、Duloxetine, 60 mg Once Daily, for Major Depressive Disorder: A Randomized Double-Blind Placebo-Controlled Trial 9、Goldstein DJ, Mallinckrodt C, Lu Y, Demitrack MA. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial. J Clin Psychiatry. 2002; 63: 225–31 10、Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria 11、Robert D. Leone, Liang Zhao, Judson M. Englert, et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion[J]. Science, 2019. 12、The Adverse Effect Profile and Efficacy of Divalproex Sodium Compared With Valproic Acid: A Pharmacoepidemiology Study 13、Gastrointestinal tolerance of divalproex sodium 14、临床实践指南:原发性肾上腺皮质功能不全的诊断和治疗 (2016版) 15、《欧洲原发性肾上腺皮质功能减退症的诊断, 治疗和随访共识 (2013版) 》 16、《临床实践指南:肾上腺皮质功能不全 (包括肾上腺危象) 的诊断和治疗 (2016版) 》 17、© 2019 Solid Oral Dose Process Validation, Volume Two Lifecycle Approach Application Authors: Pazhayattil, A., Sayeed-Desta, N., Fredro-Kumbaradzi, E., Ingram, M., Collins, J. 18、See 1 citation found by title matching your search: Nihon Rinsho. 1988 Jan;46(1):18-24. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical efficacy and problems; muscarine M1 receptor blockaders]. [Article in Japanese] 19、Journal of the American Chemical Society, 1981, vol. 103, # 9, p. 2361 - 2371 20、Hanish SI, Stein DM, Scalea JR, Essien EO, Thurman P, Hutson WR, et al. Molecular Adsorbent Recirculating System Effectively Replaces Hepatic Function in Severe Acute Liver Failure. Ann Surg. 2017;266(4):677-84. 21、Infant with 3β-hydroxy-△5-C27 steroid dehydrogenase deficiency：report of two cases and literatures review 22、 A case of congenital bile acid synthesis disorder type 2 and literature review ------ 一例先天性胆汁酸合成障碍2型患儿的临床及遗传学分析 Clinical feature and genetic analysis of a family affected by congenital bile acid synthesis defect type 2: identification of 2 novel mutations in AKR1D1 gene 23、Clinical features of a Chinese infant with inborn error of bile acid metabolism 3β-hydroxy-△5-C27 steroid dehydrogenase deficiency and review of the literature 24、3B-hydroxy-△5-C27 steroid dehydrogenase deficiency in one famny：two cases report 25、Iddon, Brian; Nicholas, Martin Journal of the Chemical Society - Perkin Transactions 1, 1996, # 12 p. 1341 - 1347/2、Vereshchagin, L. I.; Maksikova, A. V.; Tikhonova, L. G.; Buzilova, S. R.; Sakovich, G. V. 26、Chemistry of Heterocyclic Compounds (New York, NY, United States), 1981 , vol. 17, # 5 p. 510 - 515 Khimiya Geterotsiklicheskikh Soedinenii, 1981 , # 5 p. 688 - 693 27、3B-hydroxy-△5-C27 steroid dehydrogenase deficiency: a case report